There are more treatment options for reducing intraocular pressure in glaucoma than ever before and currently ophthalmologists are combining eye drops to achieve lower therapeutic targets. However, often they forget the systemic side effects – and physicians are unaware of them. Drs Paul Diggory, Alexander Spratt and Lola Ogunbowale review the risks of, and barriers to, effective glaucoma therapy.